Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China flag China · Delayed Price · Currency is CNY
16.97
-0.30 (-1.74%)
Aug 24, 2026, 3:00 PM CST

SHA:605369 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
55.7551.51171.63109.13326.04310.99
Depreciation & Amortization
97.2199.6893.6283.9941.2321.81
Other Amortization
4.573.31.921.73--
Loss (Gain) From Sale of Assets
0.40.050.020.010.1-9.96
Asset Writedown & Restructuring Costs
27.6426.151.242.61.4810.43
Loss (Gain) From Sale of Investments
0.589.32-11.48-6.50.62-4.65
Provision & Write-off of Bad Debts
3.423.424.52-0.352.61-
Other Operating Activities
42.125.77-0.5810.37-22.655.48
Change in Accounts Receivable
37.335.52-37.36-4.36-53.49-45.66
Change in Inventory
-0.03-5.07-21.613.75-12.03-51.69
Change in Accounts Payable
27.3638.5410.16-19.06-22.7117.54
Change in Other Net Operating Assets
3.812.371.472.8819.9213.41
Operating Cash Flow
294.36253.96210.38185.39282.75372.99
Operating Cash Flow Growth
34.23%20.71%13.48%-34.43%-24.19%54.01%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-131.98-111.6-109.61-121.82-172.18-275.56
Sale of Property, Plant & Equipment
0.210.1900.010.0511.85
Cash Acquisitions
--18.98-5.36-275.58--
Investment in Securities
-124.0549.81-87.86-0.1749.21-45
Other Investing Activities
0.5-7.30.14-40.18-7.98
Investing Cash Flow
-255.32-80.59-195.53-397.43-163.1-316.69

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-24560---
Total Debt Issued
24524560---
Long-Term Debt Repaid
--136.21-68.63-0.59-0.69-0.35
Total Debt Repaid
-226.21-136.21-68.63-0.59-0.69-0.35
Net Debt Issued (Repaid)
18.79108.79-8.63-0.59-0.69-0.35
Issuance of Common Stock
14.6314.63--1.6830.87
Repurchase of Common Stock
---38.88-5.12-0.69-
Common Dividends Paid
-36.9-65.68-81.23-90.1-155.43-144
Other Financing Activities
-22.987.510.5---
Financing Cash Flow
-26.4665.24-118.23-95.8-155.13-113.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-34.27-13.948.92.2830.88-5.76
Net Cash Flow
-21.7224.67-94.49-305.56-4.59-62.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
162.38142.35100.7763.57110.5797.43
Free Cash Flow Growth
74.41%41.26%58.53%-42.51%13.49%-27.08%
Free Cash Flow Margin
13.92%12.53%9.04%6.52%7.53%8.16%
Free Cash Flow Per Share
0.720.640.460.290.500.44
Levered Free Cash Flow
118.8989.0123.44-41.455.517.15
Unlevered Free Cash Flow
122.4292.5425.23-40.555.537.17

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
27.882729.6320.3198.0482.59
Change in Working Capital
62.6934.75-50.5-15.57-66.6938.9